Search Results

You are looking at 101 - 110 of 551 items for :

  • neuroendocrine cancer x
  • All content x
Clear All
Free access

Sunil Amin, Richard R P Warner, Steven H Itzkowitz, and Michelle Kang Kim

studies investigating the incidence of additional primary cancers among patients with neuroendocrine tumors (NETs) have been either autopsy studies or limited by small sample sizes ( Alexander & Altemeier 1968 , Gerstle et al . 1995 , Habal et al

Free access

Martin B Niederle, Monika Hackl, Klaus Kaserer, and Bruno Niederle

.1677/ERC-07-0221 . Hauso O Gustafsson BI Kidd M Waldum HL Drozdov I Chan AK Modlin IM 2008 Neuroendocrine tumor epidemiology: contrasting Norway and North America . Cancer 113 2655 – 2664 doi:10.1002/cncr.23883 . Helland SK Prosch

Free access

Christodoulos P Pipinikas, Alison M Berner, Teresa Sposito, and Christina Thirlwell

chromatin state of cancer cells ( Valastyan et al. 2012 ). It has been previously implicated in prostate cancer neuroendocrine differentiation ( Chang et al. 2018 ), while its overexpression results in alterations in H3K27me and increases the metastatic

Free access

J Hadoux, D Malka, D Planchard, J Y Scoazec, C Caramella, J Guigay, V Boige, S Leboulleux, P Burtin, A Berdelou, Y Loriot, P Duvillard, C N Chougnet, D Déandréis, M Schlumberger, I Borget, M Ducreux, and E Baudin

high-grade neuroendocrine tumours? Cancer Chemotherapy and Pharmacology 59 637 – 642 . ( doi:10.1007/s00280-006-0306-6 ). Baudin E 2007 Gastroenteropancreatic endocrine tumors: clinical characterization before therapy . Nature Clinical

Free access

Matthias Beyens, Timon Vandamme, Marc Peeters, Guy Van Camp, and Ken Op de Beeck

, Heldin & Westermark 1999 ). Angiogenesis signaling in neuroendocrine tumors The demand of high vascularization density for nutrient delivery to the growing tumor is one of the hallmarks of cancer ( Hanahan & Weinberg 2011 ). Pinato et al

Free access

P H Kann, E Balakina, D Ivan, D K Bartsch, S Meyer, K-J Klose, Th Behr, and P Langer

et al. 1994 , Müller et al. 1994 , Dancygier 1995 , Nattermann et al. 1995 , Wiersema & Wiersema 1995 ). In addition, EUS enables to visualize small neuroendocrine tumours down to a diameter of 1–2 mm can be visualized ( Kann et al

Free access

Jennifer A Chan, David P Ryan, Andrew X Zhu, Thomas A Abrams, Brian M Wolpin, Paige Malinowski, Eileen M Regan, Charles S Fuchs, and Matthew H Kulke

E Buzzoni R Mariani L Carnaghi C Somma L Zilembo N di Leo A 1996 Clinical efficacy of octreotide in the treatment of metastatic neuroendocrine tumors. A study by the Italian Trials in Medical Oncology Group . Cancer 77 402 – 408

Free access

Florian Bösch, Katharina Brüwer, Annelore Altendorf-Hofmann, Christoph J Auernhammer, Christine Spitzweg, C Benedikt Westphalen, Stefan Boeck, Gabriele Schubert-Fritschle, Jens Werner, Volker Heinemann, Thomas Kirchner, Martin Angele, and Thomas Knösel

with metastatic GEP-NETs . Journal of Cancer 7 484 – 489 . ( ) 26958083 10.7150/jca.13711 Kloppel G Anlauf M 2005 Epidemiology, tumour biology and histopathological classification of neuroendocrine tumours of

Free access

Maho Shibata and Michael M Shen

2010 Characterizing the contribution of stem/progenitor cells to tumorigenesis in the Pten −/− TP53 −/− prostate cancer model . Stem Cells 28 2129 – 2140 . ( doi:10.1002/stem.538 ). Abrahamsson PA di Sant'Agnese PA 1993 Neuroendocrine

Free access

Vincenzo Marotta, Maria Chiara Zatelli, Concetta Sciammarella, Maria Rosaria Ambrosio, Marta Bondanelli, Annamaria Colao, and Antongiulio Faggiano

histological neuroendocrine differentiation has not been reported, such as primary hepatocellular cancer ( Spadaro et al . 2005 ) and breast cancer ( Giovanella et al . 2001 ). To date, the capability of circulating CgA in discriminating NEN from other